(redirected from Proton pump inhibitors)
Also found in: Thesaurus, Medical.
Related to Proton pump inhibitors: omeprazole


A drug of the proton pump inhibitor class, C16H14F3N3O2S, used to treat esophagitis caused by gastroesophageal reflux disease and other disorders associated with increased gastric acid secretion.

[lanso-, origin unknown + -prazole, antiulcer drug suff.; see omeprazole.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lansoprazole - antacid (trade name Prevacid) that suppresses acid secretion in the stomach
acid - any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt


n lansoprazol m
Mentioned in ?
References in periodicals archive ?
The authors of this study found that 86% of the patients were in the moderate- or high-risk group for nonsteroidal anti-inflammatory drugs (NSAIDs)-related gastrointestinal (GI) bleeding and that 81% of these patients were not using proton pump inhibitors (PPIs).
In conclusion, we wanted to emphasize that cross-reactivity between proton pump inhibitors (PPIs) should be considered before HP treatment in patients with allergies to PPIs in our case report.
Proton pump inhibitors (PPI) are therapeutically most efficient drugs in nonerosive reflux disease treatment though complete symptom control is low.
Objective: To identify the spectrum of organisms in intensive care unit (ICU) in patients who were receiving proton pump inhibitors for stress ulcer prophylaxis and diagnosed as having hospital-acquired pneumonia (HAP).
Proton pump inhibitors I (PPIs) may be associated with decreases in serum magnesium laboratory values to below 1.6 to 1.8 mg/dL, especially when used concurrently with diuretics and loop diuretics (strength of recommendation [SOR]: C, disease-oriented outcomes based on cohort, case-control, and cross-sectional studies).
We have read the article "Atrial fibrillation in patients with gastroesophageal reflux disease: A comprehensive review" with great interest, and the authors have concluded that atrial fibrillation is more prevalent in patients with Gastroesophageal reflux disease (GERD).1 They also mentioned that use of proton pump inhibitors (PPIs) help prevent atrial fibrillation.
Eligible patients will continue to take proton pump inhibitors and be randomised to placebo or IW-3718 1500 mg twice a day for eight weeks.
Proton pump inhibitors (PPIs) are frequently prescribed antiulcer agents in the hospital.
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results from the PARIS registry.
Many Americans take proton pump inhibitors (PPIs), such as omeprazole (Prilosec), to treat gastroesophageal reflux disease.
Proton pump inhibitors (PPIs) are medications that relieve GERD (acid reflux) symptoms by reducing the amount of acid your stomach produces.